George Whitesides Net Worth (2023) | wallmine ben suarez bread / joseph wiley kim burrell / trinity memorial funeral home : muscle shoals, alabama obituaries Prior to our spin-off from Innoviva in June 2014 and since the inception of Innoviva in 1996, Dr. Whitesides served as a director of Innoviva. Flowers University Research Professor, Department of Chemistry and Chemical Biology, Walker Prize (Museum of Science, Boston) (2017), Lifetime Achievement Award (Xconomy Awards) (2017), Rieke Award in Organometallic Chemistry (U. Nebraska) (2018). [29], Whitesides has served on advisory committees for the National Science Foundation, NASA, and the Department of Defense. a net , During the past 18 months, 140,513 shares of Theravance Biopharma Inc (TBPH) were sold and 0 shares were bought by its insiders, resulting in a net In 1998, he received the U.S. National Medal of Science, In 2003, the Kyoto Prize in Materials Science and Engineering and in 2005, the Welch Award in Chemistry. Other key executives at Innoviva Inc include Professor George M. Whitesides, Harvard University: "Soft Robotics" As of 11 August 2017 he still owns at least 4,000 units of Theravance Biopharma Inc stock. Bushwick Bill Biography; Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS. Whitesides attended secondary school at Phillips Andover, graduating in 1957. of 11,026,781 shares. The estimated Net Worth of George M Whitesides is at least $379 dollars as of 11 August 2017. estimated net worth of George M Whitesides, Select a Column Field to add to the results, Refer a Friend and Earn One Month of Free Membership. PMID: 20000334 DOI: 10.1021/ac9013989 Abstract Microfluidic paper-based analytical devices (microPADs) are a new class of point-of-care diagnostic devices that are inexpensive, easy to use, and designed . Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. purchase Slow Crack Growth in Single-Crystal Silicon. He has served as a coach for Zero Gravity Corporation's parabolic flight service. 5 Relationship, Married, Affair. It was chemistry to solve problems, not necessarily to do chemistry. To be detailed, the average return of stocks after 3 months bought by George M Whitesides is 19.38%. Northwestern (Physics Tree) Yujie. His surface chemistry work has examined the process of molecules arranging themselves on a surface. [26] Two key challenges were identified as being essential to American scientific and engineering prowess: 1) creating high-quality jobs for Americans and 2) addressing the nation's need for clean, affordable, and reliable energy. This investment adviser does not provide advice to individual investors. Dr. George M. Whitesides Ph.D. serves as Independent Director of the Company., serves as an Independent Director of Company. Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Flowers University Professor at Harvard,[14] one of only 24 University Professorships at the institution as of 2014. Maureen Gardner auf LinkedIn: #comingsoon #plusyou #employeeengagement sale George Whitesides Net Worth (2023) | wallmine It develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). You might contact George M Whitesides via mailing address: C/o Advanced Magnetics Inc, 61 Mooney Street, Cambridge Ma 02138. George Whitesides is 80, he's been the Independent Director of Theravance Biopharma Inc since 2013. Woodford L. and Ann A. Enjoy a 7-Day Free Trial Thru Mar 11, 2023! Former Virgin Galactic Exec George Whitesides Runs for Congress in Identities Podcasts . George Whitesides Net Worth (2023) | wallmine All Rights Reserved. sale With good reason: He's cofounded a dozen . 8. On average, George trades about 364 units every 0 days since 2014. Whitesides is active in multiple public service roles. Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table. Roberts) in 1964. . George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $34,480 and over the last 8 years he sold TBPH stock worth over $0. Both microscale and nanoscale techniques are based on printing, molding and embossing, and can be used for the fabrication of patterns and features on many different materials. GuruFocus tracks the stock performance after each of George M Whitesides's buying transactions within different timeframes. This teacher recommended that his parents send him to Phillips Academy Andover, known for the elite preparatory school. [54][55] He was awarded the F. A. The oldest executive at Theravance Biopharma Inc is BurtonMalkiel, 87, who is the Independent Director. In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . Net worth score. Identities Podcasts People Ai. Insiders are limited to only officers and/or directors of the company. These companies include Nano Terra, Genzyme, GelTex, Theravance, Surface Logi, and WMR Biomedical. His father is George M. Whitesides, a professor of chemistry at Harvard University. and North Carolina State: The Wolfpack is 41 st in the NET. Being the son of a chemical engineer, he was exposed to science from a young age. and [37] According to the Hirsch index, a ranking which combines number of articles published and citations of those articles by others, he was the most influential living chemist in 2011. Whitesides was Virgin Galactic's CEO from 2010 to 2020, before shifting to a role as the company's chief space officer last year when the company brought on Michael Colglazier as CEO. George M Whitesides | Whitesides Research Group - Harvard University Their findings were summarized what is now known as the Whitesides Report. Other key executives at Theravance Biopharma Inc include a net Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. He was a faculty member of the Massachusetts Institute of Technology from 1964 to 1982. TED Talks. A lab the size of a postage stamp - TED Flowers University Professor and a Director of Kavli Institute for Bionano Science and Technology at Harvard University. The committee developed four areas of recommendations, with twenty specific proposals for implementable actions. He is best known for his work in the areas of NMR spectroscopy organometallic chemistry molecular self-assembly soft lithography microfabrication microfluidics and nanotechnology. The estimated Net Worth of George M Whitesides is at least $378 Thousand dollars as of 11 August 2017. George M. Whitesides was born August 3, 1939 in Louisville, KY. They criticized academic chemistry for an "increasingly incurious and risk-averse attitude" and for focusing on "familiar questions of familiar disciplines" rather than taking a broad interdisciplinary view and exploring new areas. To be detailed, the average return of stocks after 3 months bought by George M Whitesides is 19.38%. Virgin Galactic former CEO George Whitesides on next spaceflight - CNBC In 1982 Whitesides moved to Harvard, where he is currently Woodford L. and Ann A. A native of Kentucky, Whitesides earned a bachelors degree from Harvard in 1960 and 1964 with his advisor John D. Roberts (a fellow NMS recipient), a doctorate in chemistry from the California Institute of Technology. "[16], Whitesides' interests include "physical and organic chemistry, materials science, biophysics, complexity and emergence, surface science, microfluidics, optics, self-assembly, micro- and nanotechnology, science for developing economies, molecular electronics, catalysis, energy production and conservation, origin of life, rational drug design, cell-surface biochemistry, simplicity, and infochemistry. Millions of dollars. David C Duffy, Olivier J A Schueller, Scott T Brittain, George M Whitesides; Engineering. George M. WhitesidesGMW1939-. There are 1 older and 26 younger executives at Theravance Biopharma Inc. Past performance is a poor indicator of future performance. George M Whitesides owns 237,054 shares of Theravance Biopharma Inc (TBPH) as of August 11, 2017, with a value of $2 Million. Please note GuruFocus will not track the insiders transaction performance if he/she does not have buying transactions. The most-recent trade in Theravance Biopharma Inc is the Stock quotes provided by InterActive Data. Organometallic chemistry, Nuclear magnetic, Resonance spectroscopy, molecular self-assembly, soft lithography, microfabrication, microfluidics, and nanotechnology are the best work of Whitesides. Jeff Foust March 5, 2021. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. George M. Whitesides - Wikipedia purchase George M Whitesides a scientist was born August 3, 1939, in the beautiful city of Louisville, KY. a net Whitesides was the Chairman of the Reusable Launch Vehicle Working Group of COMSTAC, the advisory committee for the FAA's Commercial Space Transportation Division. The estimated Net Worth of George M Whitesides is at least $372 Tausend dollars as of 11 August 2017. Roberts) in 1964. Flowers University Professor. He is a member of the editorial boards of 15 scientific journals. He ended up remaining in Massachusetts to attend Harvard University as an undergraduate. 10 percent owner Camber Capital Management Llc [24], Whitesides is also known for publishing his "outline system" for writing scientific papers. Based on ownership reports from SEC filings, as the reporting owner, George M Whitesides owns 4 companies in total, including If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. among others of 3,437 shares made by Rhonda Farnum Learn about George M. Whitesides Net Worth, Biography, Age, Birthday, Height, Early Life, Family, Dating, Partner, Wiki, and Facts. director & Executive Chair Harlan Waksal [8], More recent research interests include energy,[22] the origin of life,[23] and science for developing economics. For innovative and far-ranging research in chemistry, biology, biochemistry and material science, pioneering work of technological interest and his extensive involvement with teaching, government and industry. sale sale Whitesides"" - - Other key executives at Theravance Biopharma Inc include In summary, during the past 3 months, insiders sold 50,000 shares of Theravance Biopharma Inc (TBPH) in total and bought 0 shares, with a net Over the last 9 years, insiders at Theravance Biopharma Inc have traded over $11,236,367 worth of Theravance Biopharma Inc stock and bought 1,509,589 units worth $29,986,811,853,500 10 percent owner Eli Samaha Interim CFO Brian Piekos sale Chief Accounting Officer Marianne Zhen Reputation Score: 1.49 - 3.12. The company recently received Food and Drug Administration approval for Feraheme, a novel iron replacement drug for CKD patients suffering from anemia, and also offers GastroMARK, an imaging aid used with magnetic resonance imaging. Scientific Advisory Boards (2010 - present): MC-10, Sun Catalyix, Reliance Corporation (India, 2009-2016); NextGen Jane (2014- ); Breakthrough Energy Ventures (2017 -); Jana Care (2017 -)Boards of Directors (2000 - present; *= current)Genzyme (co-founder), Rohm and Haas, Dexter, Hughes Research Laboratory, Advanced Magnetics, Assemblon, Concurrent Biomedical, Theravance*, Theravance Biopharma*, Surface Logix, Nano-Terra (Founder)*, Arsenal Vascular*, Lyra Therapeutics* Diagnostics for All (501-c-3, Founder)*, MC 10 Corporation, Soft Robotics (Founder)*Editorial BoardsAngewandte Chemie, Langmuir, Small, Lab on a Chip, Soft Robotics.Research InterestsChemistry, materials science, biophysics, the role of water in biomolecular recognition, the hydrophobic effect, complexity and emergence, surface science, microfluidics, paper as a material, self-assembly, micro- and nanotechnology, healthcare for developing economies, catalysis, origin of life, dissipatice systems, soft robotics, rational drug design, simplicity, and infochemistry. Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. () , An icon used to represent a menu that can be toggled by interacting with this icon. [8] He used NMR spectroscopy to study rate of change of Grignard reagents[9] and the structure of Grignard reagents in solution. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $37,800 and over the last 8 years he sold TBPH stock worth over $0. Niagara Falls, NY. Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. NEXT ARTICLE. Research and Inventions of George M Whitesides have worked in an unusually broad range of areas, including organometallic chemistry, nuclear magnetic resonance (NMR) spectroscopy, applied enzymology, self-assembly, soft lithography, microfluidics, organic surface science, and nanotechnology. He is best known for his work in the areas of nuclear magnetic resonance spectroscopy, organometallic chemistry, molecular self-assembly, soft lithography,[3] microfabrication, microfluidics, and nanotechnology. George M Whitesides is the director of Theravance Biopharma Inc. purchase . These companies include Genzyme, GelTex, Theravance, Surface Logix, Nano Terra, and WMR Biomedical. [40], Among other awards, Whitesides is the recipient of the American Chemical Society's ACS Award in Pure Chemistry (1975),[41] the Arthur C. Cope Award (1995),[42] National Medal of Science (1998),[43][44] the Kyoto Prize in Materials Science and Engineering (2003),[45] the Gabbay Award (2004),[46] the Dan David Prize (2005),[47] the Welch Award in Chemistry (2005),[48] the AIC Gold Medal (2007),[49] and the Priestley Medal (2007), the highest honor conferred by the ACS. of 22,076 shares made by Richard A Graham [62], Whitesides and his wife, Barbara, have two sons, George T. and Ben. George Whitesides Net Worth (2022) | wallmine Postdoctoral Fellow, Harvard University, G. M. Whitesides Group. (2022) Charge Transport Measured Using the EGaIn Junction through Self-Assembled Monolayers Immersed in Organic Liquids.The Journal of Physical Chemistry. George Thomas Whitesides is an American businessman. The estimated Net Worth of George M Whitesides is at least $378 Mille dollars as of 11 August 2017. George McClelland Whitesides - of 22,076 shares made by Richard A Graham Whitesides. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. Browse the library of TED talks and speakers. stock. , 3 Net Worth, Salary, House. [61] In 2022 he received the Kavli Prize in Nanosciences. The most active insiders traders include Plc Gsk, Inc. Innoviva,, and Deepika Pakianathan. . The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Flowers University Research Professor. . George Whitesides: A lab the size of a postage stamp | TED Talk. SVP & Chief Financial Officer Aziz Sawaf George M Whitesides - Google Scholar Reputation Score: 0.82 - 2.17. of 5,924,170 shares made by Perceptive Life Sciences Master Fund Ltd . Science. Its research is focused in the areas of inflammation and immunology. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.